EUVIMEDEUVIMED entdecken
Crossref

Configuration‐Mediated Efficient Non‐Radiative Transition for R848‐Assisted Photothermal Immunotherapy to Inhibit Tumor Growth and Metastasis by An In Situ Tumor Vaccine Strategy

Jianan Dai, Laiping Fang, Xuan Wang, Jie Hua, Yike Tu, Shufang Li, Kuo He, Lifeng Hang, Yuan Xu, Jin Fang, Lina Wang, Jin Wang und 2 weitere

Angewandte Chemie International Edition · 2025

DOI: 10.1002/anie.202417871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Jianan Dai und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Information Technology, Jilin Engineering Research Center of Optoelectronic Materials and Devices, Jilin Normal University, Siping, 136000…. Hauptthemen laut MEDLINE: Immunotherapy, Cancer Vaccines, Photothermal Therapy, Imidazoles. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jilin Province, 2023 Postdoctoral Workstation Project of Guangdong Second Provincial General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer metastasis remains a critical factor contributing to the current limitations in cancer treatment. Photothermal immunotherapy has emerged as a safe and potent therapeutic approach, demonstrating the capability to suppress tumor growth and metastasis. While researchers have extensively investigated various structural modifications to enhance photothermal conversion performance, the influence of molecular configuration has received comparatively limited attention. In this study, we synthesized two isomers, CZTBT and LVTBT, which possessed distinct configurations. LVTBT, characterized by a flatter molecular configuration, exhibited an extended absorption wavelength and a higher molar extinction coefficient. Its excited state facilitated stronger rotation for non‐radiative transitions, leading to a high photothermal conversion efficiency (PCE) of 36.3 %. When combined with R848, LVTBT@R848 nanoparticles (NPs)‐mediated photothermal immunotherapy functioned as an in situ tumor vaccine, promoting the maturation of dendritic cells (DCs), T cell infiltration, and the differentiation of natural killer (NK) cells and memory T cells, thereby activating the strong immune response. Consequently, it significantly inhibited the growth of both primary and distant tumors, while also limiting lung metastasis. In summary, this study proposed a configuration‐mediated non‐radiative transition strategy for efficient photothermal immunotherapy, advancing the frontiers of organic photothermal agents (OPTAs) design and synthesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyCancer VaccinesPhotothermal TherapyImidazolesAntineoplastic AgentsNeoplasmsAnimalsMiceNanoparticlesCell ProliferationHumansCell Line, Tumor

Stichwörter der Autor:innen

configuration changesin situ tumor vaccinenon-radiative transitionphotothermal immunotherapy

Substanzen

Cancer VaccinesImidazolesAntineoplastic Agents

Autor:innen und Institutionen

  • College of Information Technology, Jilin Engineering Research Center of Optoelectronic Materials and Devices, Jilin Normal University, Siping, 136000, P. R. China.
  • Jilin Provincial Key Laboratory of Wide Bandgap Semiconductor Material Growth and Device Applications, Jilin Normal University, Changchun, 130103, P. R. China.
  • Guangdong Second Provincial General Hospital, School of Medicine, Jinan University, Guangzhou, 518037, P. R. China.
  • The Department of Medical Imaging, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, 518037, P. R. China.
  • State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130012, P. R. China.
  • Medical Ethics Office, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, 518037, P. R. China.

ORCID-Profile: Ping'an Ma

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jilin Province
  • 2023 Postdoctoral Workstation Project of Guangdong Second Provincial General Hospital
  • Lifting Project of Guangdong Second Provincial General Hospital
  • China Postdoctoral Science Foundation
  • Major Research Plan of the National Natural Science Foundation of China
  • Guangzhou Key Laboratory of Molecular Functional Imaging
  • Experts and Youths Project of Guangdong Second Provincial General Hospital

Zitieren

APA

Dai, J., Fang, L., Wang, X., Hua, J., Tu, Y., Li, S., He, K., Hang, L., Xu, Y., Fang, J., Wang, L., Wang, J., Ma, P., & Jiang, G. (2025). Configuration‐Mediated Efficient Non‐Radiative Transition for R848‐Assisted Photothermal Immunotherapy to Inhibit Tumor Growth and Metastasis by An In Situ Tumor Vaccine Strategy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202417871

Vancouver

Dai J, Fang L, Wang X, Hua J, Tu Y, Li S, et al. Configuration‐Mediated Efficient Non‐Radiative Transition for R848‐Assisted Photothermal Immunotherapy to Inhibit Tumor Growth and Metastasis by An In Situ Tumor Vaccine Strategy. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202417871

BibTeX
@article{Dai2025,
  author = {Dai, Jianan and Fang, Laiping and Wang, Xuan and Hua, Jie and Tu, Yike and Li, Shufang and He, Kuo and Hang, Lifeng and Xu, Yuan and Fang, Jin and Wang, Lina and Wang, Jin and Ma, Ping'an and Jiang, Guihua},
  title = {Configuration‐Mediated Efficient Non‐Radiative Transition for R848‐Assisted Photothermal Immunotherapy to Inhibit Tumor Growth and Metastasis by An In Situ Tumor Vaccine Strategy},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  doi = {10.1002/anie.202417871}
}
Kostenlos starten →